We are live on
!
Find out more
QC
Quadrature Capital Portfolio holdings
AUM
$11.7B
1-Year Est. Return
87.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$9.8B
AUM Growth
+$1.34B
(+16%)
Cap. Flow
+$1.32B
Cap. Flow
% of AUM
13.46%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
1,749
New
756
Increased
260
Reduced
198
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$299M |
| 2 |
Strategy Inc
MSTR
|
+$174M |
| 3 |
ServiceNow
NOW
|
+$152M |
| 4 |
Advanced Micro Devices
AMD
|
+$149M |
| 5 |
TSMC
TSM
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$282M |
| 2 |
Royal Bank of Canada
RY
|
+$265M |
| 3 |
Robinhood
HOOD
|
+$258M |
| 4 |
Palantir
PLTR
|
+$194M |
| 5 |
Apple
AAPL
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.12% |
| 2 | Consumer Discretionary | 12.45% |
| 3 | Industrials | 11.48% |
| 4 | Financials | 10.67% |
| 5 | Healthcare | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Biomea Fusion
BMEA
$92.1M
| $86.7K | ﹤0.01% |
69,932
-18,330
| -21% | -$25.7K |
|
|
HIO
1127
Western Asset High Income Opportunity Fund
HIO
$338M
| $86.3K | ﹤0.01% |
+23,257
| New | +$88.1K |
|
|
AUTL
1128
Autolus Therapeutics
AUTL
$551M
| $84.3K | ﹤0.01% |
42,341
-314,922
| -88% | -$484K |
|
1129
LG Display
LPL
$3.36B
| $83.7K | ﹤0.01% |
19,889
-21,531
| -52% | -$101K |
|
1130
Bridger Aerospace
BAER
$80.6M
| $81.5K | ﹤0.01% |
+44,558
| New | +$77.8K |
|
1131
Rayonier Advanced Materials
RYAM
$593M
| $81.5K | ﹤0.01% |
13,843
-4,160
| -23% | -$27K |
|
|
ACOG
1132
Alpha Cognition
ACOG
$194M
| $81.3K | ﹤0.01% |
12,501
-1,141
| -8% | -$7.21K |
|
1133
Tronox
TROX
$993M
| $80.4K | ﹤0.01% |
19,281
-10,032
| -34% | -$38.2K |
|
1134
SmartRent
SMRT
$261M
| $78.3K | ﹤0.01% |
38,770
-24,837
| -39% | -$40.7K |
|
1135
NN Inc
NNBR
$300M
| $77.4K | ﹤0.01% |
+60,475
| New | +$92.5K |
|
1136
Aemetis
AMTX
$120M
| $77.3K | ﹤0.01% |
+55,581
| New | +$112K |
|
|
EARN
1137
Ellington Residential Mortgage REIT
EARN
$164M
| $74.8K | ﹤0.01% |
+14,202
| New | +$74.4K |
|
|
DGNX
1138
Diginex Ltd
DGNX
$50.6M
| $74.3K | ﹤0.01% |
+2,226
| New | +$247K |
|
1139
Mercer International
MERC
$34.2M
| $73.3K | ﹤0.01% |
+37,009
| New | +$78K |
|
1140
United States Antimony
UAMY
$988M
| $71.3K | ﹤0.01% |
14,204
-49,924
| -78% | -$392K |
|
1141
BigBear.ai
BBAI
$1.55B
| $69.2K | ﹤0.01% |
+12,821
| New | +$83.8K |
|
|
EM
1142
DELISTED
Smart Share Global Ltd
EM
| $69.2K | ﹤0.01% |
+59,126
| New | +$78.8K |
|
1143
James River Group Holdings
JRVR
$210M
| $68K | ﹤0.01% |
10,688
-10,147
| -49% | -$58.4K |
|
1144
Context Therapeutics
CNTX
$41.6M
| $67.9K | ﹤0.01% |
+46,220
| New | +$54K |
|
|
ACRE
1145
Ares Commercial Real Estate
ACRE
$256M
| $66.5K | ﹤0.01% |
+13,916
| New | +$67.6K |
|
1146
Compass Therapeutics
CMPX
$400M
| $66K | ﹤0.01% |
12,293
-35,134
| -74% | -$162K |
|
1147
Cingulate
CING
$70.7M
| $65.9K | ﹤0.01% |
+15,182
| New | +$58.6K |
|
1148
Inovio Pharmaceuticals
INO
$76.1M
| $64.8K | ﹤0.01% |
37,222
+107
| +0.3% | +$236 |
|
|
BGL
1149
Blue Gold Ltd
BGL
$8.13M
| $64.7K | ﹤0.01% |
+33,709
| New | +$196K |
|
1150
Health Catalyst
HCAT
$127M
| $64.3K | ﹤0.01% |
+26,888
| New | +$73.5K |
|
Similar funds
BCI
VA
PI
UE
LC
DWM
ERSOT
Quadrature Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Quadrature Capital held 1,749 positions worth $9.8B, up 16% from $8.45B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Quadrature Capital deployed $1.32B of net new capital in Q4 2025, opening 756 new positions and adding to 260 existing holdings. Its largest new stake was UnitedHealth: 882,161 shares worth $291M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Royal Bank of Canada, an estimated $265M trimmed.
- Quadrature Capital's largest Q4 2025 buy was UnitedHealth: 882,161 shares worth $291M.
- Quadrature Capital added most to Advanced Micro Devices in Q4 2025, an estimated $149M increase.
- Quadrature Capital's biggest Q4 2025 reduction was Royal Bank of Canada, cutting an estimated $265M.
- Quadrature Capital fully exited NVIDIA in Q4 2025, selling an estimated $282M.
- Quadrature Capital's ten largest holdings make up 22% of its $9.8B portfolio in Q4 2025.
- Quadrature Capital opened 756 new positions and closed 532 in Q4 2025.
- Quadrature Capital's portfolio value rose 16% quarter-over-quarter to $9.8B.
Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.